ModeX is dedicated to developing next-generation multispecific biologics for cancers and infectious diseases. ModeX’s platforms unite the power of multiple biologics in a single molecule to create multispecific antibodies and vaccines with unprecedented versatility and potency against complex diseases. In May 2022, we merged with OPKO Health to begin a major new phase for both companies as a united entity with a shared visio...
ModeX is dedicated to developing next-generation multispecific biologics for cancers and infectious diseases. ModeX’s platforms unite the power of multiple biologics in a single molecule to create multispecific antibodies and vaccines with unprecedented versatility and potency against complex diseases. In May 2022, we merged with OPKO Health to begin a major new phase for both companies as a united entity with a shared vision for transforming medicine.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.